Rhee, E. G., Rizk, M. L., Calder, N., Nefliu, M., Warrington, S. J., Schwartz, M. S., . . . Butterton, J. R. (2018). Erratum for Rhee et al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants”. Antimicrob Agents Chemother.
Chicago Style CitationRhee, Elizabeth G., et al. "Erratum for Rhee Et Al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination With Imipenem and Cilastatin in Healthy Participants”." Antimicrob Agents Chemother 2018.
Cita MLARhee, Elizabeth G., et al. "Erratum for Rhee Et Al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination With Imipenem and Cilastatin in Healthy Participants”." Antimicrob Agents Chemother 2018.